Norris Medicines, a company in the Trading & Distributors industry, reported revenue of ₹0.66 crore and a net loss of ₹0.36 crore for the September 2026 quarter.
Norris Medicines (BSE: NORRIS) closed at ₹14.07 on 20 Nov 2026, down 13.7% over the past year. Its market capitalisation is ₹14 crore.
Incorporated in 1990, Norris Medicines Ltd is a manufacturer of Injections and Medicinal formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.